Celebrex Linked To Increased Heart Attack Risk

Law360, New York (April 2, 2008, 12:00 AM EDT) -- A recent study has revealed that large doses of Pfizer Inc.’s pain medication Celebrex may increase the risk of cardiovascular events in patients, cautioning doctors against prescribing high doses of the drug to patients with a history of such events.

The study, sponsored by the National Cancer Institute and presented Monday at the American College of Cardiology’s annual meeting, found that patients taking a 400-mg dose of Celebrex twice daily had three times the risk of cardiovascular events, such as heart attack or stroke, compared to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.